Hansa Biopharma interim report January-March 2024
/PRNewswire/ -- Hansa Biopharma, the pioneer in immunomodulatory enzyme technology for rare IgG mediated diseases, today announced its business update and...
Source: prnewswire.com
Approval Study News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Approval Study. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Approval Study Today - Breaking & Trending Today
Real-world MitraClip Impact in Secondary MR: Reassuring for Some, Not All
In practice, patients are a little sicker and are not receiving GDMT, which is a problem, believes one HF expert.
Source: tctmd.com
S-ICD Shows Virtues, Limits in 'Real World' Postmarket Study
The subcutaneous-lead ICD's strengths and weaknesses in a registry study mirrored its performance in earlier trials, 11 years after its US approval.
Source: medscape.com